Cargando…
Research progress of ghrelin on cardiovascular disease
Ghrelin, a 28-aminoacid peptide, was isolated from the human and rat stomach and identified in 1999 as an endogenous ligand for the growth hormone secretagogue-receptor (GHS-R). In addition to stimulating appetite and regulating energy balance, ghrelin and its receptor GHS-R1a have a direct effect o...
Autores principales: | Yuan, Ming-Jie, Li, Wei, Zhong, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823193/ https://www.ncbi.nlm.nih.gov/pubmed/33427286 http://dx.doi.org/10.1042/BSR20203387 |
Ejemplares similares
-
Venous endothelial function in cardiovascular disease
por: Dardi, Patrizia, et al.
Publicado: (2022) -
Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity
por: Querfeld, Uwe, et al.
Publicado: (2020) -
Inflammation: a putative link between phosphate metabolism and cardiovascular disease
por: Voelkl, Jakob, et al.
Publicado: (2021) -
Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease
por: Geissler, Andrew, et al.
Publicado: (2020) -
Polymorphism rs7214723 in CAMKK1: a new genetic variant associated with cardiovascular diseases
por: Beghi, Sofia, et al.
Publicado: (2021)